Cargando…
Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
BACKGROUND: Chronic pain is a common cause of reduced quality of life. Recent studies suggest that chronic pain patients have a different brain neurometabolic status to healthy people. Proton magnetic resonance spectroscopy ((1)H-MRS) can determine the concentrations of metabolites in a specific reg...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293371/ https://www.ncbi.nlm.nih.gov/pubmed/28203104 http://dx.doi.org/10.2147/JPR.S123403 |
_version_ | 1782505067370250240 |
---|---|
author | Ito, Takahiro Tanaka-Mizuno, Sachiko Iwashita, Narihito Tooyama, Ikuo Shiino, Akihiko Miura, Katsuyuki Fukui, Sei |
author_facet | Ito, Takahiro Tanaka-Mizuno, Sachiko Iwashita, Narihito Tooyama, Ikuo Shiino, Akihiko Miura, Katsuyuki Fukui, Sei |
author_sort | Ito, Takahiro |
collection | PubMed |
description | BACKGROUND: Chronic pain is a common cause of reduced quality of life. Recent studies suggest that chronic pain patients have a different brain neurometabolic status to healthy people. Proton magnetic resonance spectroscopy ((1)H-MRS) can determine the concentrations of metabolites in a specific region of the brain without being invasive. PATIENTS AND METHODS: We recruited 56 chronic pain patients and 60 healthy controls to compare brain metabolic characteristics. The concentrations of glutamic acid (Glu), myo-inositol (Ins), N-acetylaspartate (NAA), Glu + glutamine (Glx), and creatine + phosphocreatine (total creatine [tCr]) in the anterior cingulate cortex of participants were measured using (1)H-MRS. We used age- and gender-adjusted general linear models and receiver-operating characteristic analyses for this investigation. Patients were also assessed using the Hospital Anxiety and Depression Scale (HADS) to reveal the existence of any mental health issues. RESULTS: Our analysis indicates that pain patients have statistically significantly higher levels of Glu/tCr (p=0.039) and Glx/tCr (p<0.001) and lower levels of NAA/tCr than controls, although this did not reach statistical significance (p=0.052). Receiver-operating characteristic analysis performed on the combination of Glx/tCr, Ins/tCr, and NAA/tCr effectively discriminated chronic pain patients from healthy controls. Patients with higher HADS-Depression scores had increased Glx/rCr levels (p=0.015), and those with higher HADS-Anxiety scores had increased NAA/tCr levels (p=0.018). CONCLUSION: Chronic pain patients have a different metabolite status in the anterior cingulate cortex to controls. Within the pain patient group, HADS scores had a positive relationship with NAA/tCr and Glx/tCr levels. (1)H-MRS successfully detected metabolic changes in patients’ brains in a noninvasive manner, revealing its potential as a superior diagnostic tool for pain patients. |
format | Online Article Text |
id | pubmed-5293371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-52933712017-02-15 Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls Ito, Takahiro Tanaka-Mizuno, Sachiko Iwashita, Narihito Tooyama, Ikuo Shiino, Akihiko Miura, Katsuyuki Fukui, Sei J Pain Res Original Research BACKGROUND: Chronic pain is a common cause of reduced quality of life. Recent studies suggest that chronic pain patients have a different brain neurometabolic status to healthy people. Proton magnetic resonance spectroscopy ((1)H-MRS) can determine the concentrations of metabolites in a specific region of the brain without being invasive. PATIENTS AND METHODS: We recruited 56 chronic pain patients and 60 healthy controls to compare brain metabolic characteristics. The concentrations of glutamic acid (Glu), myo-inositol (Ins), N-acetylaspartate (NAA), Glu + glutamine (Glx), and creatine + phosphocreatine (total creatine [tCr]) in the anterior cingulate cortex of participants were measured using (1)H-MRS. We used age- and gender-adjusted general linear models and receiver-operating characteristic analyses for this investigation. Patients were also assessed using the Hospital Anxiety and Depression Scale (HADS) to reveal the existence of any mental health issues. RESULTS: Our analysis indicates that pain patients have statistically significantly higher levels of Glu/tCr (p=0.039) and Glx/tCr (p<0.001) and lower levels of NAA/tCr than controls, although this did not reach statistical significance (p=0.052). Receiver-operating characteristic analysis performed on the combination of Glx/tCr, Ins/tCr, and NAA/tCr effectively discriminated chronic pain patients from healthy controls. Patients with higher HADS-Depression scores had increased Glx/rCr levels (p=0.015), and those with higher HADS-Anxiety scores had increased NAA/tCr levels (p=0.018). CONCLUSION: Chronic pain patients have a different metabolite status in the anterior cingulate cortex to controls. Within the pain patient group, HADS scores had a positive relationship with NAA/tCr and Glx/tCr levels. (1)H-MRS successfully detected metabolic changes in patients’ brains in a noninvasive manner, revealing its potential as a superior diagnostic tool for pain patients. Dove Medical Press 2017-01-31 /pmc/articles/PMC5293371/ /pubmed/28203104 http://dx.doi.org/10.2147/JPR.S123403 Text en © 2017 Ito et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Ito, Takahiro Tanaka-Mizuno, Sachiko Iwashita, Narihito Tooyama, Ikuo Shiino, Akihiko Miura, Katsuyuki Fukui, Sei Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls |
title | Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls |
title_full | Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls |
title_fullStr | Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls |
title_full_unstemmed | Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls |
title_short | Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls |
title_sort | proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293371/ https://www.ncbi.nlm.nih.gov/pubmed/28203104 http://dx.doi.org/10.2147/JPR.S123403 |
work_keys_str_mv | AT itotakahiro protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols AT tanakamizunosachiko protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols AT iwashitanarihito protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols AT tooyamaikuo protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols AT shiinoakihiko protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols AT miurakatsuyuki protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols AT fukuisei protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols |